Condition
Recurrent Non-Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Non-Hodgkin Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Non-Hodgkin Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Genetically engineered CAR T-cells for treating certain blood cancers | Phase 1 | Columbus, Ohio and 1 other locations | Recruiting | Jun 14, 2022 |
| CAR-T therapy for HIV-related aggressive B-cell lymphoma | Phase 1 | Duarte, California and 6 other locations | Recruiting | Oct 14, 2021 |
| Tegavivint treatment for recurrent or refractory solid tumors in children | Phase 1/2 | Birmingham, Alabama and 20 other locations | Recruiting | Apr 20, 2021 |
| Personalized NK cell therapy after umbilical cord blood transplant for leukemia | Phase 2 | Houston, Texas | Recruiting | Apr 5, 2016 |
All recruiting trials (4)
-
Genetically engineered CAR T-cells for treating certain blood cancers
This study is testing a new type of treatment using specially modified immune cells to see if they can help people with certain blood cancers that haven't responded to other treatments.
-
CAR-T therapy for HIV-related aggressive B-cell lymphoma
This study is testing a new CAR-T therapy to see if it can safely help people with HIV-related aggressive B-cell lymphoma that hasn't responded to other treatments.
-
Tegavivint treatment for recurrent or refractory solid tumors in children
This study tests if a new intravenous medication called tegavivint can help children with tough-to-treat solid tumors, like Ewing sarcoma and desmoid tumors, by finding the right dose and seeing how well it works.
-
Personalized NK cell therapy after umbilical cord blood transplant for leukemia
This study is testing if a special treatment using personalized immune cells from umbilical cord blood can help people with leukemia feel better after their transplant.
Related topics
Quick answers
How many Recurrent Non-Hodgkin Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.